Time-Restricted Eating vs Traditional Dieting for Obesity
(NY-TREAT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores two different eating approaches to aid weight loss and improve metabolism in people with obesity. One group will follow time-restricted eating (TRE), consuming all meals within a 10-hour window each day. The other group will maintain their usual eating schedule, spread over 13 hours or more, known as Habitual Prolonged Eating Duration (HABIT). The researchers aim to determine if TRE can reduce the risk of heart problems compared to traditional eating patterns. Individuals aged 50 to 75 with obesity and conditions like prediabetes or diet-controlled type 2 diabetes may be suitable candidates.
As an unphased trial, this study provides a unique opportunity to contribute to understanding how different eating patterns can impact health and potentially improve quality of life.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, it excludes those using medications that affect sleep, circadian rhythms, or metabolic function, so you may need to discuss your specific medications with the trial team.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that time-restricted eating (TRE) can aid in weight loss and improve insulin levels. This method involves eating only during a specific number of hours each day. Some studies have found that TRE can help individuals lose 3%–5% of their body weight within a few months. However, some participants might experience minor issues such as nausea, headaches, or changes in sleep patterns.
Overall, TRE appears to be well-tolerated, but individual responses can vary. Prospective participants should consult their doctor about any concerns before joining a study.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores two different approaches to eating schedules for addressing obesity. Traditional dieting often focuses on counting calories or specific food restrictions, but the TRE (Time-Restricted Eating) method is unique because it limits the time window for eating to 10 hours or less each day. This method might help regulate metabolism and improve weight management without requiring participants to change what they eat, just when they eat. The HABIT group, meanwhile, maintains a typical eating schedule, which allows researchers to compare the effects of time-restricted eating against a more conventional approach. This trial could reveal new insights into how timing, rather than just diet content, impacts obesity.
What evidence suggests that this trial's treatments could be effective for obesity?
This trial will compare Time-Restricted Eating (TRE) with a Habitual Prolonged Eating Duration (HABIT) approach. Studies have shown that TRE can aid in weight loss and improve health. Research indicates that individuals using TRE can lose about 3% to 5% of their body weight over a few months. TRE has also been linked to lower fasting insulin levels and enhanced fat burning. Participants in TRE programs often experience improvements in blood pressure and mood. These findings suggest that TRE might help reduce the risk of diseases like type 2 diabetes and heart disease by supporting weight loss and better metabolic health.13678
Who Is on the Research Team?
Blandine Laferrère, M.D., Ph.D.
Principal Investigator
Columbia University
Are You a Good Fit for This Trial?
This trial is for English-speaking adults aged 50-75 in the NYC area, with a BMI of 25-45 and conditions like hypertension, prediabetes or type 2 diabetes controlled by diet/metformin. Participants should have stable weight, eat breakfast habitually, and own a smartphone. Exclusions include smokers, those with severe diseases or sleep disorders, previous bariatric surgery patients, heavy alcohol consumers, and certain medication users.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to either a time restricted eating (TRE) window of 10 hours or a habitual eating window of 13 hours, with self-monitoring via a smartphone application
Follow-up
Participants are monitored for changes in body weight, fat mass, insulin resistance, and other metabolic markers
What Are the Treatments Tested in This Trial?
Interventions
- HABIT
- TRE
Find a Clinic Near You
Who Is Running the Clinical Trial?
Columbia University
Lead Sponsor
National Institute on Aging (NIA)
Collaborator
New York University
Collaborator
Salk Institute for Biological Studies
Collaborator